Search

Showing "11155" results for ""

Atazanavir levels reduced during pregnancy, especially when used with tenofovir

Sex and drug use driving HCV epidemic among HIV-positive gay men in Australia; other study shows small epidemic in US

Acute and chronic kidney disease

Vigilance needed over MDR-TB in children, South African doctors warn

Gardasil safe and effective in young men

Atazanavir dose adjustment in pregnancy approved by US FDA

Treatment interruptions explain higher HIV viral load in patients with depression and those who use stimulants

Bone loss a general side-effect of HIV therapy, suggests small study

Little evidence of transmission of virus that's resistant to newer anti-HIV drugs

Warning issued to Fuzeon, Pegasys, Viraferon Peg and Intron A users

What's happening to benefits?

HIV prevention: does scaring people work?

From Kenya to Kennington

Towards a cure for all (part one)

A winter of discontent?

Huge decline in HIV rates in Zimbabwe driven by fear of infection

Managing kidney disease in people living with HIV

NNRTIS and PIs equal in children, trials shows, but PIs may delay need for switch to second-line

Receive the latest HIV research and conference news

Showing "11155" results for ""

Atazanavir levels reduced during pregnancy, especially when used with tenofovir

Sex and drug use driving HCV epidemic among HIV-positive gay men in Australia; other study shows small epidemic in US

Acute and chronic kidney disease

Vigilance needed over MDR-TB in children, South African doctors warn

Gardasil safe and effective in young men

Atazanavir dose adjustment in pregnancy approved by US FDA

Treatment interruptions explain higher HIV viral load in patients with depression and those who use stimulants

Bone loss a general side-effect of HIV therapy, suggests small study

Little evidence of transmission of virus that's resistant to newer anti-HIV drugs

Warning issued to Fuzeon, Pegasys, Viraferon Peg and Intron A users

What's happening to benefits?

HIV prevention: does scaring people work?

From Kenya to Kennington

Towards a cure for all (part one)

A winter of discontent?

Huge decline in HIV rates in Zimbabwe driven by fear of infection

Managing kidney disease in people living with HIV

NNRTIS and PIs equal in children, trials shows, but PIs may delay need for switch to second-line

Receive the latest HIV research and conference news